News

Insurance companies are paring down plans for patients, impacting patient ability to choose physicians. Dermatologists are being terminated from some plans based on practice profiling software that has insufficient risk analysis.

Potential errors related to EHRs include out-of-date medication lists, cut-and-paste incongruities and failure to heed electronically generated warnings, experts say.

Researchers have identified gene variants that could lead to new treatment targets and a better understanding of rosacea.

Maui – Taken together, two new studies suggest that among teens, indoor tanning is linked with other risky behaviors, and that tanners may be seeking a sort of natural high. This information may help dermatologists discuss healthy living in general with patients.

Key developments in battling sexually transmitted viruses include a new version of the HPV vaccine that protects against nine strains, and continued progress against HSV, says an expert.

A doctor performing a cosmetic filler injection is sued for battery by a patient. Consent was obtained, no untoward event happened and there were no long-term complications.

A new study, however, strongly refutes Silver sulfadiazine as being the gold standard for treating wounds. Learn why.

Researchers have identified the previously uncharacterized microtubule-severing enzyme, Fidgetin-like 2 (FL2), as a potential therapeutic target

A team of dermatologists tried to determine whether purse-string sutures improve cosmetic outcome, healing time, and scarring, when compared with second-intention healing for circular defects on the trunk and extremities. Get results from their findings

Growth factors are one of the most controversial cosmetic ingredients in terms of safety. Learn why.

Social media, an up-to-date web site, and a regular email newsletter highlighting what is new in your practice are ways to market yourself and your practice. Experts at the 2015 AAD also advise developing relationships with plastic surgery peers and carrying products for purchase at the office.

While non-physician clinicians cannot replace dermatologists, the role they play in dermatology practices is growing. However, there are key factors to consider, one expert says, including team structure, supervision and training.

Dermatologists should learn to recognize some rare and common skin conditions that may result from emerging medical therapies.

Dermatologists should refrain from developing an initial clinical impression and consider alternative diagnoses when seeing patients, an expert tells colleagues at the 73rd annual meeting of the American Academy of Dermatology.

While BDD is present in 2.4% of the general population, it can range from 9 - 14% in dermatology clinics. There are red flags that dermatologists can watch for, and depending on the severity, dermatologists may consider referring patients to mental health professionals.

Dermatologists should know the etiology of patient ulcers to most effectively manage them, according to an expert at AAD. He offered keys for treating wounds.

Two of the most vexing skin conditions dermatologists manage are melasma and vitiligo. Seemal Desai, M.D., board-certified dermatologist, clinical assistant professor in the department of dermatology at University of Texas, Southwestern Medical Center in Dallas, and medical director of Innovative Dermatology, discusses treatment options.

Outcomes for patients with Merkel Cell Carcinoma are typically poor and therapeutic options are limited, but advances in understanding the biology of the disease, as well as emerging cutting-edge treatments are expected to improve the outlook, experts say.

Does hair conditioner make an excellent shaving cream? to find out the answer keep reading.

Ipilimumab has been evaluated in the adjuvant setting. One expert predicts that ipilimumab’s positive effect on progression-free survival will translate into improvements in overall survival; however, he cautions that there is a risk:benefit ratio to be weighed.

An active ingredient used in the treatment of glaucoma is showing promise as a nonsurgical option in the reduction of periorbital fat.

Emerging therapies for rosacea have a favorable side effect profile and address specific symptoms of the condition; brimonidine, for example, addresses background erythema while ivermectin addresses the papules and pustules.

Study details how a topical gel helped bring “significant relief” to patient’s severe pain and itching. Find out how

Adam DeGraide, CEO of Crystal Clear Digital Marketing talks with John B. Lazor, M.D., M.B.A., F.A.C.S., of the New England Cosmetic Surgery and Laser Center in Weymouth, Mass. The two discuss the value of using before and after photos to educate patients on the results achievable using injectables.

Study finds that treatment with erlotinib may be beneficial in selected head-and-neck squamous-cell carcinoma cases

[Mentoring] “teaching” per se; although, education is usually a part of the process. Mentoring is more the action of providing help or assistance in dealing with some problem or issue that the mentee is having difficulty in dealing with it.

This 17-year-old patient presents with discolored skin spots on the trunk; scales and peeling over lesions; chronic occurrence. Video from the Doctor's Channel.

dermatologists have all experienced the patient who comes in stating that no antiperspirant works, even prescription aluminum chloride solutions. So what do you tell them? Read to learn more.

Mohs dermatologists and other surgeons should collaborate in the treatment of patients with squamous cell carcinoma to improve patient survival and recurrence rates, according to an expert who presented an outcomes poster at the annual meeting of the American Academy of Otolaryngology-Head and Neck Surgery Foundation.

New agent approvals over the last several years and even better ones in the pipeline have displaced older therapies and improved outcomes for patients with melanoma. Some physicians say, the future may bring a cure.